Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »

For full access to this article login to GEN Select now.

Jan 20, 2014

Top 25 M&A Deals of 2013

Find out which big fish were devoured by larger ones last year.

Top 25 M&A Deals of 2013

Most 2013 deals involved big biotechs, and even several big pharmas, snapping up smaller biopharmas. [© Yuri Arcurs - Fotolia.com]

  • #10. Santarus

    Acquired by: Salix Pharmaceuticals

    Price: $2.6 billion

    Deal Status: Announced November 7; deal expected to close in the first quarter of 2014.

    Premium: 36% premium ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »